86 related articles for article (PubMed ID: 24330966)
1. [The effects of gastric bypass procedures on blood glucose, gastric inhibitory polypeptide and glucagon-like peptide-1 of normal glucose tolerance dogs].
Pan LZ; Bai RX; Song MM; Li YG; Zhou L; Zhong ZQ; Xu J; Yuan HS; Cui Z
Zhonghua Wai Ke Za Zhi; 2013 Sep; 51(9):831-3. PubMed ID: 24330966
[TBL] [Abstract][Full Text] [Related]
2. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.
Pacheco D; de Luis DA; Romero A; González Sagrado M; Conde R; Izaola O; Aller R; Delgado A
Am J Surg; 2007 Aug; 194(2):221-4. PubMed ID: 17618808
[TBL] [Abstract][Full Text] [Related]
3. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
[TBL] [Abstract][Full Text] [Related]
4. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
[TBL] [Abstract][Full Text] [Related]
5. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
Nauck MA; Siemsglüss J; Orskov C; Holst JJ
Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
[TBL] [Abstract][Full Text] [Related]
6. Influence of New Modified Biliopancreatic Diversion on Blood Glucose and Lipids in GK rats.
Weng S; Zhang B; Xu C; Feng S; He H
Obes Surg; 2017 Mar; 27(3):657-664. PubMed ID: 27525641
[TBL] [Abstract][Full Text] [Related]
7. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
[TBL] [Abstract][Full Text] [Related]
8. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
9. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.
Lund A; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1038-46. PubMed ID: 21386059
[TBL] [Abstract][Full Text] [Related]
10. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes.
Laferrère B; Heshka S; Wang K; Khan Y; McGinty J; Teixeira J; Hart AB; Olivan B
Diabetes Care; 2007 Jul; 30(7):1709-16. PubMed ID: 17416796
[TBL] [Abstract][Full Text] [Related]
11. On the role of the gut in diabetic hyperglucagonaemia.
Lund A
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects.
Yanagimachi T; Fujita Y; Takeda Y; Honjo J; Sakagami H; Kitsunai H; Takiyama Y; Abiko A; Makino Y; Kieffer TJ; Haneda M
Mol Metab; 2017 Feb; 6(2):226-231. PubMed ID: 28180064
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test.
Armaghanian N; Hetherington J; Parameswaran V; Chua EL; Markovic TP; Brand-Miller J; Steinbeck K
Pediatr Pulmonol; 2020 Dec; 55(12):3391-3399. PubMed ID: 32955169
[TBL] [Abstract][Full Text] [Related]
15. Functional GIP receptors play a major role in islet compensatory response to high fat feeding in mice.
Moffett RC; Vasu S; Flatt PR
Biochim Biophys Acta; 2015 Jun; 1850(6):1206-14. PubMed ID: 25688757
[TBL] [Abstract][Full Text] [Related]
16. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
17. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
[TBL] [Abstract][Full Text] [Related]
18. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
[TBL] [Abstract][Full Text] [Related]
19. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
20. Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation.
Kiec-Klimczak M; Malczewska-Malec M; Razny U; Zdzienicka A; Gruca A; Goralska J; Pach D; Gilis-Januszewska A; Dembinska-Kiec A; Hubalewska-Dydejczyk A
J Physiol Pharmacol; 2016 Apr; 67(2):217-26. PubMed ID: 27226181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
